Loss of mutl disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer

Svasti Haricharan, Nindo Punturi, Purba Singh, Kimberly R. Holloway, Meenakshi Anurag, Jacob Schmelz, Cheryl Schmidt, Jonathan T. Lei, Vera Suman, Kelly Hunt, John A. Olson, Jeremy Hoog, Shunqiang Li, Shixia Huang, Dean P. Edwards, Shyam M. Kavuri, Matthew N. Bainbridge, Cynthia X. Ma, Matthew J. Ellis

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Loss of mutl disrupts CHK2-dependent cell-cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences